ASK REDCHAT ANYTHING ABOUT JAGUAR HEALTH INC.
Jaguar Health Inc. (NASDAQ: JAGX)
Listen to this Section
$2.26
-0.1200
(
-5.04% )
181.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Canalevia (crofelemer)DetailsNoninfectious diarrhea |
Approved |
| CrofelemerDetailsNoninfectious diarrhea, Chemotherapy induced nausea and vomiting |
Phase 3 |
| Crofelemer powderDetailsMicrovillus inclusion disease, Short bowel syndrome |
Phase 2 |
Market Data
|
| Open |
$2.26 |
| Previous Close |
$2.38 |
| Volume |
181.6K |
| Market Cap |
$1.72M |
| Day Range |
$2.15 - $2.59 |
| 52 Week Range |
$2.15 - $105.00 |
| Shares Outstanding |
0.72M |
| Change % |
-5.04% |
| Net Change |
▼ -0.1200 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2015 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,307,689.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-05-21 |
Sale |
-871.00 |
Chaturvedi Pravin R |
| 2024-05-21 |
Sale |
-871.00 |
Wolin Jonathan S. |
| 2024-05-21 |
Sale |
-612.00 |
King Steven R. |
| 2024-05-21 |
Sale |
-431.00 |
Lizak Carol R. |
| 2024-05-21 |
Sale |
-2695.00 |
CONTE LISA A |
| 2024-04-17 |
Sale |
-600.00 |
CONTE LISA A |
| 2024-04-17 |
Sale |
-60.00 |
Lizak Carol R. |
| 2024-04-17 |
Sale |
-134.00 |
Chaturvedi Pravin R |
| 2024-04-17 |
Sale |
-89.00 |
Wolin Jonathan S. |
| 2024-04-17 |
Sale |
-178.00 |
King Steven R. |